The performance of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key territories has introduced significant risk . Investors are now grappling with the impact of lower-cost alternat